Suggestions
Todd Meyerrose
Healthcare founder and investor
Todd Meyerrose is an experienced entrepreneur, investor, and advisor based in the San Francisco Bay Area.1 He is currently a Founder at Navio, a company that delivers personalized resources to cancer patients to improve engagement and treatment adherence.12 Meyerrose is also a Co-Founder of Lexent Bio, which was acquired by Roche/Foundation Medicine.1
As an investor, Meyerrose has invested in several biotech and healthcare startups, including Osmind, a precision medicine platform for mental health.13 He is also a Founding Partner at BioMed Ventures, a private wealth office focused on early-stage venture investments across industries.1
Education and Academic Involvement
Meyerrose holds:
- A BS in Biology from the University of Kentucky
- A PhD in Craniofacial Biology and Development from the University of Southern California
- A PhD in Molecular Cell Biology from Washington University School of Medicine in St. Louis1
He currently serves as a Consulting Associate Professor at Stanford University, where he co-directs a course on Biotechnology Business and Finance in the School of Medicine.1
Other Roles and Investments
Meyerrose is an advisor to several companies, including ixlayer and Genome Medical, Inc.1 His investment portfolio includes companies such as:
- FaunaBio
- RxLive
- Rondo Therapeutics
- Halo Biosciences
- Pragma Bio (formerly VastBiome)
- Mediphage Bioceuticals
- HALO Diagnostics
- MedAnswers
- Boost Biomes1
